-
The largest cardiovascular companies had plenty of news to crow about in the latter part of February and early March as they jockeyed for position in various key sectors of the cardiovascular device market. Boston Scientific (Natick, Massachusetts) made the biggest news, reporting on March 4 that it had received its much-anticipated FDA approval to market the Taxus Express2 paclitaxel-eluting coronary stent system.
-
-
-
Cognitive Effects of Estrogen Therapy; Vitamin Therapy and Restenosis; Echinacea and the Common Cold; Effects of Paxil in Children Under 18; FDA Actions.
-
-
The womens health initiative reported their results on cognition and dementia combining the canceled estrogen-only arm with the canceled estrogen-progestin arm of the randomized trial; the data are derived from an ancillary study of the trial entitled The Womens Health Initiative Memory Study (WHIMS).
-
It was a challenge issued to the beat of a step class, the pace of a race walk, the strength of a stream of push-ups. The reward for the team who won the Fitness Challenge at DeKalb Medical Center in Decatur, GA: $1,000 to split and a paid day off.
-
Brace yourself for a tough flu season. Absenteeism could become an issue for many hospitals as unvaccinated employees with respiratory symptoms miss days of work.
-
Federal enforcement of the annual fit-testing requirement has been halted for at least a year, as Congress intervened in the tuberculosis-related rule. Meanwhile, new draft federal TB guidelines leave some ambiguity by recommending periodic fit-testing, while acknowledging regulations that require annual fit-testing.
-
